Kim JE, Jung HJ, Lee YJ, Kwon TH. Vasopressin-regulated miRNAs and AQP2-targeting miRNAs in kidney collecting duct cells. Am J Physiol Renal Physiol 308: F749 -F764, 2015. First published January 28, 2015 doi:10.1152/ajprenal.00334.2014.-Mature microRNA (miRNA) acts as an important posttranscriptional regulator. We aimed to profile vasopressin-responsive miRNAs in kidney inner medullary collecting duct cells and to identify aquaporin-2 (AQP2)-targeting miRNAs. Microarray chip assay was carried out in inner medullary collecting duct tubule suspensions from rat kidneys in the absence or presence of desmopressin (dDAVP) stimulation (10 Ϫ9 M, 2 h). The results demonstrated 19 miRNAs, including both precursor and mature miRNAs, as potential candidates that showed significant changes in expression after dDAVP stimulation (P Ͻ 0.05). Nine mature miRNAs exhibiting Ͼ1.3-fold changes in expression on the microarray (miR-127, miR-1, miR-873, miR-16, miR-206, miR-678, miR-496, miR-298, and miR-463) were further examined by quantitative real-time PCR, and target genes of the selected miRNAs were predicted. Next, to identify AQP2-targeting miRNAs, in silico analysis was performed. Four miRNAs (miR-32, miR-137, miR-216a, and miR216b) target the 3=-untranslated region of rat AQP2 mRNA. Target seed regions of miR-32 and miR-137 were also conserved in the 3=-untranslated region of mouse AQP2 mRNA. Quantitative realtime PCR and immunoblot analysis demonstrated that dDAVPinduced AQP2 expression was significantly attenuated in mpkCCDc14 cells when cells were transfected with miRNA mimics of miR-32 or miR-137. Moreover, luciferase reporter assay demonstrated a significant decrease of AQP2 translation in mpkCCDc14 cells transfected with miRNA mimics of miR-32 or miR-137. The present study provides novel insights into the regulation of AQP2 by RNA interference; however, vasopressin-regulated miRNAs did not include miR-32 or miR-137, indicating that the interaction of miRNAs with the AQP2 regulatory pathway requires further analysis.
The results demonstrated 19 miRNAs, including both precursor and mature miRNAs, as potential candidates that showed significant changes in expression after dDAVP stimulation (P Ͻ 0.05). Nine mature miRNAs exhibiting Ͼ1.3-fold changes in expression on the microarray (miR-127, miR-1, miR-873, miR-16, miR-206, miR-678, miR-496, miR-298, and miR-463) were further examined by quantitative real-time PCR, and target genes of the selected miRNAs were predicted. Next, to identify AQP2-targeting miRNAs, in silico analysis was performed. Four miRNAs (miR-32, miR-137, miR-216a, and miR216b) target the 3=-untranslated region of rat AQP2 mRNA. Target seed regions of miR-32 and miR-137 were also conserved in the 3=-untranslated region of mouse AQP2 mRNA. Quantitative realtime PCR and immunoblot analysis demonstrated that dDAVPinduced AQP2 expression was significantly attenuated in mpkCCDc14 cells when cells were transfected with miRNA mimics of miR-32 or miR-137. Moreover, luciferase reporter assay demonstrated a significant decrease of AQP2 translation in mpkCCDc14 cells transfected with miRNA mimics of miR-32 or miR-137. The present study provides novel insights into the regulation of AQP2 by RNA interference; however, vasopressin-regulated miRNAs did not include miR-32 or miR-137, indicating that the interaction of miRNAs with the AQP2 regulatory pathway requires further analysis.
aquaporin-2; collecting duct; microRNA; RNA interference; vasopressin THE KIDNEY COLLECTING DUCT is an important renal tubular segment for the regulation of body water and salt homeostasis. Water reabsorption in collecting duct cells is regulated by arginine vasopressin (AVP) via vasopressin V2 receptors (V2Rs) (9) . AVP increases the osmotic water permeability of collecting duct cells through aquaporin-2 (AQP2) (13, 14, 20) . AVP induces the apical targeting of AQP2 and transcription of the AQP2 gene in kidney collecting duct principal cells (4, 19, 27) . A number of previous studies have demonstrated transcriptional and posttranscriptional regulation of AQP2 and the critical role of AQP2 in the homeostasis of body water balance (8, 18) . However, microRNA (miRNA), an important posttranscriptional modulator (2) , has been poorly understood in kidney collecting duct cells, particularly for the regulation of AQP2 expression.
miRNA is a modulator in the posttranscriptional regulation through inhibition of translation of target mRNA via translational regression of the RNA-induced silencing complex (15) . Mature miRNA (20 -22 nucleotides in length) is produced in the cytosol by the dicer, which cleaves a hairpin of precursor miRNA (pre-miRNA) transported from the nucleus. miRNA specifically interacts with the 3=-untranslated region (UTR) of target mRNA by base pairing based on the sequence specificity. The degree of complementarity of the miRNA is important for the recognition of an mRNA by a targeting miRNA (28) . Recent studies using in silico sequence analysis have suggested that miRNA has multiple target mRNAs and also shares target mRNAs with other miRNAs. Upon this property of miRNA, miRNAs build complicated regulatory networks under physiological and pathophysiological conditions. Recently, microarray chip assay of miRNA has demonstrated the expression of miRNAs in the rat kidney (25) , and several miRNAs have been emerged as important modulators of protein expression in pathophysiological conditions, including diabetic nephropathy (e.g., miR-192) and renal fibrosis (e.g., miR-192, miR-200, miR-21, and miR-377) (5, 10, 11) . In particular, inhibition of miR-21 was protective against transforming growth factor (TGF)-␤-induced fibrogenesis and inflammation in glomerular and interstitial cells (6) . miR-192, which is expressed in the kidney cortex, also plays a role in the regulation of Na ϩ transport (16) . In the present study, we aimed to identify vasopressinresponsive miRNAs in kidney inner medullary collecting duct (IMCD) cells by exploiting microarray chip assay. Moreover, target genes of the selected miRNAs and their biological functions and processes were predicted by in silico analysis. Furthermore, we specifically predicted miRNAs targeting AQP2 expression by in silico analysis, and two predicted AQP2-targeting miRNAs (miR-32 and miR-137) were further investigated to understand a novel molecular mechanism of AQP2 protein regulation. The present study provides novel insights on the regulation of AQP2 protein expression, at least in part, via RNA interference, i.e., AQP2-targting miRNAs.
MATERIALS AND METHODS
RNA purification from IMCD tubule cells from rat kidneys. Animal protocols were approved by the Animal Care and Use Committee of Kyungpook National University. Fresh IMCD tubules were prepared from rat kidneys as previously described (3, 23) . Briefly, the inner medulla was isolated from male Sprague-Dawley rats (6 wk old), and IMCDs were collected by centrifugation. The IMCD tubule suspension was incubated in medium in the absence or presence of desmopressin (dDAVP; 10 Ϫ9 M) for 2 h with gentle shaking at 37°C. Total RNA was purified using the mirVana miRNA isolation kit (Ambion) according to the manufacturer's instructions. The concentration and purity of total RNA were measured using NanoDrop (Thermo Scientific, Wilmington, DE).
To examine the purity of the IMCD preparation, we made three different samples from the inner medullary suspension. As previously demonstrated (3), one-third of the inner medullary suspension from the rat kidney was collected without fractionation ("whole inner AQP2 (rat)  5=-GTTTCTCTGTTACCCTGGG-3=  5=-GTGATCATCAAACTTGCCAG-3=  AQP2 (mouse)  5=-GTTTCTCTGTTACCCTGGM-3=  5=-GTGATCATCAAACTTGCC-3=  Sgk3 (mouse)  5=-GCCTGGGCGCTGTTCT-3=  5=-AGCAACATCTCGGCAGTAAAA-3=  Tgif1 (mouse)  5=-AGAGAAGGAGGAGAGGCAATC-3=  5=-CAGCCAGTCTCGCAGAATC-3=  Traf3 (mouse) 5=-CGACTGCAAAGAAAAAGTACTGA-3= 5=-CGGTATTTACAGGCCTTTTCC-3= Mapkapk2 (mouse) 5=-AGGAGACCAGGCATTCACA-3= 5=-CTCGCCGATGCTCTTCA-3= Gpr137b (mouse) 5=-GACCTTGCCTGGAACATTG-3= 5=-AATCATAGTAGTCTGGAGCAAAACTT-3= Myo1c (mouse) 5=-GTCAGACACCTCGGCTACAAG-3= 5=-GGGAAATCGGATGAAGATCTTA-3= Mylk (mouse) 5=-GAGCGGGAGTGCATCAAGTA-3= 5=-TGCCCTGCTTGTGGATGTA-3= ␤-Actin (rat) 5=-CCTTCTTGGGTATGGAATCC-3= 5=-TTGGCATAGAGGTCTTTACG-3= ␤-Actin (mouse) 5=-CCTTCTTGGGTATGGAAT-3= 5=-TTGGCATAGAGGTCTTTA-3= AQP2, aquaporin 2; Sgk3, serum/glucocorticoid-regulated kinase 3; Tgif1, transforming growth factor ␤-induced factor homeobox 1; Traf3, TNF receptor-associated factor 3; Gpr137b, G protein-coupled receptor 137b; Myo1c, myosin 1c; Mylk, myosin light chain kinase. medulla"). The remaining two-thirds of the inner medullary suspension was subjected to three low-speed centrifugations (each at 80 g for 30 s) to separate IMCD tubule fragments in the pellets ("IMCD enriched") from the lighter non-IMCD structures in the supernatants ("non-IMCD"). Samples were homogenized and solubilized in Laemmli buffer [10 mm Tris (pH 6.8), 1.5% SDS, 6% glycerol, 0.05% bromphenol blue, and 40 mm DTT] before being loaded for SDS-PAGE.
Microarray of miRNA expression. Isolated total RNA (1 g) was labeled by biotin using the FlashTag Biotin HSR RNA labeling kit (Affymetrix), and miRNA expression was profiled by a GeneChip miRNA 3.0 Array (Affymetrix). Images of the microarray were scanned using GeneChip Scanner 3000 7G plus (Affymetrix), and signal intensity representing each miRNA expression was managed using Expression Console software (version 1.2.1, Affymetrix).
Quantitative real-time PCR analysis of mRNA and miRNA. The relative expression of miRNAs in total RNA isolated from IMCD tubules and mpkCCDc14 cells was analyzed using a miScript SYBR green PCR kit (QIAGEN) according to the manufacturer's instructions. cDNAs were synthesized from total RNA (1 g) using the miScript II RT kit (QIAGEN). U6 RNA was used as an internal control, and the threshold value of 0.02 recommended by the protocol was used. The relative amount of each miRNA to U6 RNA was calculated using the following formula: 2
Ϫ⌬Ct , where Ct is the threshold cycle and ⌬Ct ϭ Ct(miRNA) Ϫ Ct(U6). Primers of miRNAs were purchased from QIAGEN (miR-32: MS00000210 and miR-137: MS00000392). A capitalized "miR" refers to the mature form of the microRNA (miRNA), whereas the uncapitalized "mir" refers to the precursor form of the miRNA.
The relative expression of mRNA in mpkCCDc14 cells was assayed using the QuantiTect SYBR Green PCR kit (QIAGEN). cDNAs for PCR were synthesized from total RNA (1 g) of mpkCCDc14 cells using a PrimeScript 1st strand cDNA Synthesis Kit (Takara). Quantitated C t values were corrected by the Ct value of ␤-actin. Primer sequences are shown in Table 1 . Quantitative real-time PCR analysis of miRNA was performed using QIAGEN Rotor-Gene-Q (QIAGEN). Four reactions per miRNA or mRNA were run according to the manufacturer's protocol.
Animal models of low or high water intake. Male Sprague-Dawley rats (180 -200 g) were obtained from Charles River (Orient Bio, Seongnam, Korea). To establish an animal model of low or high water intake, male Sprague-Dawley rats were kept individually in metabolic cages for 4 days, as we have previously described (22) . For the first 2 days, both groups of rats received a daily food mixture consisting of 15 g rat chow and 25 ml tap water per rat. One group of rats then received a daily food mixture consisting of 15 g rat chow and 10 ml tap water per rat for 2 days (low water intake, n ϭ 6), and the other group received a food mixture consisting of 15 g rat chow and 35 ml tap water per rat for 2 days (high water intake, n ϭ 6). Rats in both groups consumed all of their food mixture daily and maintained their weight throughout the 4-day period. Water bottles were not provided in metabolic cages, and, hence, all rats did not drink water ad libitum.
Semiquantitative immunoblot analysis. Total lysates were prepared in RIPA buffer (10 mM Tris·HCl, 0.15 M NaCl, 1% Nonidet P-40, 1% Na-deoxycholate, 0.5% SDS, 0.02% sodium azide, and 1 mM EDTA, pH 7.4) containing proteinase and phosphatase inhibitors (0.4 g/ml leupeptin, 0.1 mg/ml Pefabloc, 1 mM Na 3VO4, 25 mM NaF, and 0.1 M okadaic acid) and quantified using a BCA protein assay kit (Pierce BCA protein assay kit). Immunoblot analysis of AQP2 and phosphorylated (p-)AQP2 (Ser 256 ) in equal amounts of total lysates was performed using 12% polyacrylamide gels, as previously described (14) . AQP2 antibody (1:10,000, final IgG dilution concentration: 100 ng/ml), purchased from Millipore (AB3066, Darmstadt, Germany), and p-AQP2 (Ser 256 , 1:3,000), a previously characterized polyclonal antibody against a PKA phosphorylation consensus site (i.e., Ser 256 ) (4), were used. AQP1 antibody, previously characterized polyclonal antibody against rat AQP1 (24) was used. Myosin light chain kinase (Mylk) antibody was purchased from Santa Cruz Biotechnology (sc-22226). Band density was quantitated by ImageJ (National Institutes of Health), and densitometry values for each protein were corrected by the densitometry value of ␤-actin.
Immunohistochemistry and in situ hybridization. Expression of AQP2 protein and AQP2-targeting miRNAs was examined in rat kidney collecting ducts and the inner medulla by immunoperoxidase labeling and in situ hybridization staining. Immunoperoxidase labeling of AQP2 and in situ hybridization of miR-32 and miR-137 were performed on serially sectioned paraffin-embedded kidney tissues (5 m thickness). For immunohistochemistry of AQP2, anti-AQP2 antibody (1:40,000, final IgG dilution concentration: 25 ng/ml), purchased from Millipore (AB3066), was used, and a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:200, P448, DAKO) was reacted for 90 min at room temperature. In situ hybridization for miR-32 or miR-137 was performed using the miRCURY LNA microRNA ISH Optimization Kit (FFPE, Exiqon) according to the manufacturer's instructions. LNA U6 snRNA (2 nM) was used as positive control; LNA scrambled miRNA probe (80 nM) was used as (20 nM) and Lipofectamine RNAiMAX Reagent, was seeded on the semipermeable filter of a transwell system. QIAGEN miScript miRNA mimics (Syn-mmu-miR-32-5p and Syn-mmumiR-137-3p) and QIAGEN miScript Inhibitor Negative Control were purchased. After 7 days in culture, cells were incubated in serum-and hormone-free medium for another 24 h (on day 8). dDAVP (10 Ϫ9 M) or vehicle was then treated on the basolateral side (lower chamber) for 24 h. For immunoblot analysis of AQP2 protein, cells were lysed using RIPA buffer containing protease inhibitors and phosphatase inhibitors. Protein concentration in the cell lysate was analyzed using the BCA assay. Total RNAs were isolated using a mirVana miRNA Isolation Kit (Ambion). Expression of AQP2 mRNA and protein was analyzed by quantitative real-time PCR and semiquantitative immunoblot analysis.
Luciferase reporter assay. To examine the specific interaction of miRNA to the target sequence of 3=-UTR of AQP2 in mpkCCDc14 cells, pmirGLO Dual-Luciferase miRNA Target Expression vector (Promega, Madison, WI) was used. The 3=-UTR sequence of mouse AQP2 (5=-CTTCCCCTCCTGTACCTGCAATAAT-3=) was inserted into pmirGLO vector. Dual luciferase assays were performed as previously described (22) using the Dual-Luciferase Reporter Assay System (Promega). The reporter constructs (0.5 g) and pRL-SV40 vector (25 ng, Promega) per well were cotransfected using 2 l Lipofectamine 2000 to mpkCCDc14 cells seeded on 60-mm dishes (Nunc) for 48 h. Cells transfected with control small interfering (si)RNA or miRNA mimic (20 nM) using Lipofectamine RNAiMAX Reagent were seeded on 24-well plates (SPL Life Sciences, Seoul, Korea). After 48 h, luciferase activity was analyzed according to the manufacturer's instructions. Briefly, cells were lysed with passive lysis buffer. Luciferase assay buffer II containing luciferase substrate was added to the lysate in 96 wells, and firefly luminescence was then measured using a luminometer (Victor X2, Perkin-Elmer, Waltham, MA). After the same volume of dual and Stop & Glo reagent was added to each well, Renilla luminescence was measured in the same plate order as firefly luminescence.
Statistical analysis. Values are shown as means Ϯ SE. Comparisons between two groups (vehicle vs. dDAVP) were made by an unpaired t-test. Comparisons among more than two groups were made by one-way ANOVA followed by a Tukey highly significant difference multiple-comparisons test. Multiple-comparisons tests were only applied when a significant difference was determined in ANOVA (P Ͻ 0.05). P values of Ͻ0.05 were considered significant. 
RESULTS
Profiling and identification of dDAVP-responsive miRNAs in rat kidney IMCDs. To examine the purity of the IMCD preparation, IMCD tubule fragments (IMCD enriched) were separated from lighter non-IMCD structures in the supernatants (non-IMCD) by centrifugation. Immunoblot analysis demonstrated that AQP2, which is highly expressed in IMCD cells (13, 19) , was exclusively expressed in the IMCD-enriched fraction, whereas AQP1 was highly expressed in the non-IMCD-enriched fraction (Fig. 1A) . This was consistent with immunoblot analysis of AQP2 (both ϳ28-kDa deglycosylated bands and ϳ35-to 50-kDa glycosylated bands) and Mylk (ϳ210-kDa bands). C and D: densitometric analysis revealed that AQP2 protein abundance was not significantly changed, whereas Mylk protein abundance was markedly decreased in IMCD tubule suspensions after dDAVP treatment. *P Ͻ 0.05. n is the number of IMCD tubule suspension preparations. Fig. 5 . Prediction of AQP2-targeting miRNAs using TargetScan 6.2. Target seed regions of miR-32 and miR-137 were predicted using TargetScan 6.2 (rat and mouse database). A: miR-32 targets the same sequences (UGCAAUA) at the 3=-untranslated region (UTR) of AQP2 mRNA of the rat and mouse. B: miR-137 targets the same sequences (GCAAUAA) at the 3=-UTR of AQP2 mRNA of the rat and mouse.
Position 481-487 of AQP2 3'UTR
previous findings showing that AQP1 is a constitutively active water channel found in descending thin limbs and the descending vasa recta in the rat kidney inner medulla (17, 21) . The results indicated that the IMCD preparation used in this study was purified. Moreover, to confirm the dDAVP response in the prepared IMCD tubule suspension, phosphorylation of AQP2 at Ser 256 (p-AQP2) was examined as a positive control, which is known to be increased by vasopressin stimulation in collecting duct principal cells via cAMP-PKA signaling activation (4). In the IMCD tubule suspension, dDAVP treatment (10 Ϫ9 M, 2 h) significantly increased AQP2 phosphorylation at Ser 256 (Fig. 1,  B and C) . Semiquantitative immunoblot analysis revealed a significant increase in the ratio of p-AQP2 (Ser 256 ) to total AQP2 in dDAVP-treated cells (353 Ϯ 15%, P Ͻ 0.05) compared with vehicle-treated cells (Fig. 1C) .
Microarray chip assay for miRNA expression was carried out using a rat miRNA microarray chip containing probes for 1,166 rat miRNAs (Affymetrix GeneChip miRNA 3.0 Array). To profile dDAVP-responsive miRNAs in IMCD cells, total RNA was purified in rat IMCD tubule suspensions treated with vehicle or the V2R-specific agonist dDAVP (10 Ϫ9 M) for 2 h (Fig. 2A) . A volcano plot showed the distribution of the fold change of total miRNAs in response to dDAVP stimulation (10 Ϫ9 M, 2 h) in IMCD cells (Fig. 2B ). Nineteen miRNAs, including both precursor and mature miRNAs, were selected as potential candidates of dDAVP-responsive miRNAs (indicated by red dots in Fig. 2B ; Table 2 ), and they exhibited a Ͼ1.3-fold change (indicated by green lines in Fig. 2B ) in expression after dDAVP stimulation (P ϭ 0.05, indicated by the yellow line in Fig. 2B ). Among the 19 miRNAs (Table 2) , miR-127, miR-1, miR-873, miR-16, miR-206, miR-678, miR-496, and miR-298 were downregulated mature miRNAs, whereas miR-463 was the upregulated mature miRNA (Fig. 2C) . In addition, six other miRNAs (miR-3548, miR-3558, miR-499, miR-338, miR-142, and miR-139) were also significantly changed by dDAVP treatment (P Ͻ 0.05; Fig. 2C) ; however, they exhibited changes of Ͻ1.3-fold.
To further examine changes of miRNA expression, which were Ͼ1.3-fold by the microarray chip assay, quantitative real-time PCR was performed in IMCD cells (Fig. 3) . Quantitative real-time PCR showed a similar pattern of changes in miRNA expression to those determined by microarray (Fig. 3) . In particular, expression of miR-298, miR-1, miR-496, miR- 127, miR-678, and miR873 was significantly decreased in IMCD cells stimulated by dDAVP (Fig. 3) , consistent with the microarray chip assay. In contrast, expression of miR-206, miR-16, and miR-463 was not consistent (Fig. 3) . In particular, quantitative real-time PCR demonstrated that miR-16 expression was significantly increased in IMCD cells after dDAVP stimulation (Fig. 3) .
Target genes of vasopressin-responsive miRNAs.
To understand the interaction between miRNAs and their target genes, target mRNAs of the selected nine miRNAs (miR-127, miR-1, miR-873, miR-16, miR-206, miR-678, miR-496, miR-298, and miR-463) that showed Ͼ1.3-fold changes by microarray chip assay (Fig. 2) after dDAVP stimulation were predicted using TargetScan (Release 6.2). Interactions between miRNA and target genes are shown in Table 3 using in silico analysis based on both total context scores (less than Ϫ0.3 cutoff) and probability of conserved targeting (Ͼ0.8 cutoff). Three miRNAs (miR-1, miR-16, and miR-206) and their targets (76 genes) were sorted by the cutoff values. The biological functions and processes of 76 genes were determined by the Automated Bioinformatics Extractor tool downloaded from the National Heart, Lung, and Blood Institute (http://helixweb.nih.gov/ ESBL/ABE/) (1). Target genes of miRNAs (miR-1, miR-16, and miR-206) and the functions of their proteins are shown in Table 4 .
The results suggest that target genes of dDAVP-responsive miRNAs could be considered as potential candidates regulated by vasopressin stimulation. Among the predicted target genes, Mylk, which is known to be involved in vasopressin-induced AQP2 translocation (3), was selected. Mylk is one of the predicted target genes of miR-16 (Tables 3 and 4) , and quantitative real-time PCR revealed that miR-16 expression was significantly upregulated in IMCD cells stimulated by dDAVP (Fig. 3) . We further examined changes in Mylk protein abundance in IMCD tubule suspensions stimulated by dDAVP (10 Ϫ9 M) for 6 h. The results demonstrated that AQP2 mRNA expression was significantly increased (163 Ϯ 21% of the vehicle-treated group, P Ͻ 0.05; Fig. 4A ), whereas AQP2 protein abundance was variable and was not significantly changed at 6 h of dDAVP stimulation (152 Ϯ 32% of the vehicle-treated group, not significant; Fig. 4, B and C) . In contrast, Mylk protein abundance was markedly decreased (58 Ϯ 7% of the vehicletreated group, P Ͻ 0.05; Fig. 4, B and D) .
AQP2-targeting miRNAs in collecting duct cells. Next, we predicted AQP2-targeting miRNAs by in silico analysis. To examine whether miRNAs could regulate the expression of vasopressin-regulated water channel protein AQP2 in collecting duct cells, miRNAs targeting AQP2 mRNA were predicted by TargetScan 6.2. Four miRNAs (miR-32, miR-137, miR216a, and miR-216b) targeting the 3=-UTR of rat AQP2 mRNA were predicted in the rat miRNA database and two miRNAs (miR-32 and miR-137) targeting the 3=-UTR of mouse AQP2 mRNA were predicted in the mouse miRNA database. They were not among the vasopressin-regulated (Table 2) . Sequences and target sequences of miR-32 and miR-137, which were predicted in both rat and mouse databases in common, are shown in Fig. 5 . Target seed regions of miR-32 and miR-137 were conserved at the 3=-UTR (476 -483) of rat AQP2 mRNA and the 3=UTR (481-488) of mouse AQP2 mRNA, respectively. In particular, target seed regions of both miR-32 and miR-137 shared target sequences in the 3=-UTR of AQP2 mRNA in both the rat and mouse. Therefore, we selected miR-32 and miR-137 and examined the role of these two miRNAs in the regulation of AQP2 expression.
Immunohistochemistry of AQP2 and in situ hybridization of miRNAs were performed in kidney tissues (Fig. 6, A-F) . In situ hybridization revealed that miR-32 and miR-137 were expressed in IMCD cells from rat kidneys (Fig. 6, E and F) , where AQP2 was abundantly expressed (Fig. 6, A and B) . Oligo probes specific for U6, used as a positive control, revealed intensified signals in IMCD cells (indicated by arrows, Fig. 6C ), whereas scrambled oligos as a negative control did not show any signals (Fig. 6D) . Oligo probes specific for miR-32 and miR-137 demonstrated positive signals in IMCD cells (possibly at principal cells, indicated by arrows, but not in intercalated cells, indicated by asterisks; Fig. 6, E and F) , but expression in other cell types in the kidney inner medulla cannot be ruled out, and further detailed studies are needed.
Decreased AQP2 protein expression in miR-32 or miR-137 overexpressed in mpkCCDc14 cells. Next, miR-32 and miR-137, both of which were expressed in kidney collecting duct cells (Fig. 6) , were examined to ascertain whether these miRNAs could regulate AQP2 protein expression. To assess whether AQP2 expression is regulated by miR-32 or miR-137, quantitative real-time PCR and semiquantitative immunoblot analysis were performed in mpkCCDc14 cells, mouse CCD cells, transfected with miRNA mimics (Fig. 7) . Transfection of miRNA mimics (20 nM) of miR-32 or miR-137 significantly increased miRNA expression in miRNA mimic-transfected cells compared with nontarget oligo-transfected cells (Fig. 7, A  and E) . Importantly, quantitative real-time PCR demonstrated that transfection of miR-32 or miR-137 mimics in mpkCCDc14 cells was associated with significantly decreased AQP2 mRNA expression (Fig. 7, B and F) . Immunoblot analysis also showed a significant decrease of AQP2 protein abundance in mpkCCDc14 cells transfected with miRNA mimics. Transfection of miR-32 mimic (20 nM) decreased AQP2 protein abundance (61 Ϯ 5% of nontarget oligo-transfected cells, P Ͻ 0.05; Fig. 7, C and D) . Moreover, miR-137 mimic transfection also reduced AQP2 protein abundance (70 Ϯ 1% of nontarget oligo-transfected cells, P Ͻ 0.05; Fig. 7, G and H) . The results indicated that miR-32 and miR-137 could play a role in the regulation of AQP2 mRNA and protein expression in collecting duct cells.
Since miR-32 and miR-137 do not specifically interact with the 3=-UTR of ␤-catenin mRNA, ␤-catenin was selected as a negative control. We performed semiquantitative immunoblot analysis of ␤-catenin in mpkCCDc14 cells transfected with miR-32 mimic or miR-137 mimic. ␤-Catenin protein abundance was unchanged in mpkCCDc14 cells where miR-32 (20 nM) or miR-137 (20 nM) was overexpressed (Fig. 8) .
Interaction of miRNA to the target sequence of the 3=-UTR of AQP2 mRNA. To clarify the direct binding of miR-32 and miR-137 to AQP2, a dual luciferase assay was performed. The target region of miR-32 or miR-137 in the AQP2 3=-UTR was inserted to pmirGLO firefly luciferase expression vector (Fig. 9A) . Both pmirGLO inserted by the miR-32 or miR-137 target sequence and pRL-SV40 Renilla luciferase expression vector were cotransfected into mpkCCDc14 cells. Thereafter, negative control siRNA or miRNA mimic was transfected, respectively. Firefly luciferase activity was significantly decreased when miR-32 mimic or miR-137 mimic was transfected (Fig. Target genes of miR-32 and miR-137. miR-32 and miR-137 could target other genes in addition to AQP2. To predict target genes of miR-32 and miR-137, four computational programs (TargetScan 6.2, miRDB, MiRanda, and DIANA microT-CDS) were run using the mouse database of miRNAs, since miRNA data were more available in the mouse than in the rat, and changes of AQP2 expression were examined in mpkCCDc14 cells, mouse CCD cells, transfected with miRNA mimics (Fig. 7) . We selected target genes that were commonly predicted from all four different computational programs. Target genes were finally chosen when these genes were also found in the mpkCCD transcriptome database (http://dir.nhlbi.nih.gov/papers/lkem/mpkccdtr/). Target genes are shown in Tables 5 and 6 .
Next, to examine whether these two miRNAs (miR-32 and miR-137) could regulate mRNA levels of these target genes, we selected several genes [serum/glucocorticoid-regulated kinase 3 (Sgk3), TGF-␤-induced factor homeobox 1 (Tgif1), and TNF receptor-associated factor 3 (Traf3) for miR-32; G protein-coupled receptor (Gpr)137b, Mapkapk2, and myosin (Fig. 10, A and B) . In a rat model of low water intake, urine output was significantly decreased (4.2 Ϯ 0.4 vs. 22.8 Ϯ 0.8 ml/day in rats with high water intake, P Ͻ 0.05), and urine osmolality was markedly increased (2,969 Ϯ 241 vs. 531 Ϯ 12 mosM/kgH 2 O in rats with high water intake, P Ͻ 0.05). Inner medullary AQP2 abundance was significantly increased in rats with low water intake (137 Ϯ 8% of rats with high water intake, P Ͻ 0.05; Fig. 11, A and B) . In contrast, quantitative real-time PCR demonstrated that expressions of miR-32 and miR-137 in the inner medulla were not significantly changed (Fig. 11, C and D) , suggesting that these two miRNAs are not regulated by vasopressin. -dependent vasopressin signaling (3, 12) . Actually, we demonstrated that Mylk protein abundance was significantly decreased in IMCD cells treated with dDAVP, consistent with a previous finding of Mylk in dDAVP-stimulated mpkCCD epithelial cells (http://helixweb.nih.gov/ESBL/Database/ProteinHalfLives/ GeneSymbolATR.html).
In the present study, in silico analysis demonstrated that two miRNAs (miR-32 and miR-137) were predicted as AQP2-targeting miRNAs in rat and mouse kidney collecting duct cells. In situ hybridization demonstrated the expression of these two miRNAs in rat IMCD cells. Interestingly, miR-32 and miR-137 were not identified as vasopressin-responsive miRNAs by microarray analysis, and this was further demonstrated in IMCD cells treated with dDAVP or in a rat model of altered water intake. However, overexpression of miR-32 or miR-137 in mpkCCDc14 cells demonstrated that these miRNAs decreased dDAVP-regulated AQP2 mRNA and protein levels. Moreover, direct binding of miR-32 or miR-137 to the 3=-UTR of AQP2 mRNA was shown in a luciferase assay using the seed region of the 3=-UTR of AQP2 mRNA, which has a complementary sequence with miR-32 or miR-137. Transfection of miR-32 or miR-137 mimics was associated with a significant decrease of luminescence in the vector, indicating that miR-32 or miR-137 directly interacted with the 3=-UTR of AQP2 mRNA. Consistent with this, quantitative real-time PCR and semiquantitative immunoblot analysis demonstrated that expression levels of AQP2 mRNA and protein were significantly decreased in miR-32-or miR-137-overexpressing mpkCCDc14 cells, confirming that both miR-32 and miR-137 are AQP2-targeting miRNAs in kidney collecting duct cells. Therefore, this would appear to be vasopressin-independent regulation of AQP2.
Several genes have been demonstrated to be importantly involved in the regulation of intracellular trafficking and protein expression of AQP2 (12, 26) . In particular, eight genes [AVP receptor 2 (Avpr2), protein kinase, cAMP-dependent, regulatory, type I␣ (Prkar1a), guanine nucleotide-binding protein, ␣-stimulating complex locus (Gnas), calmodulin 1 (Calm1), phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit-␣ (Pik3ca), Akt1, TBC1 domain family, member 4 (Tbc1d4), and Rho GTPase activating protein 5 (Arhgap5)], which are important in the regulation of AQP2 (12) , were selected to predict miRNAs targeting these genes. As shown in Table 7 , the observed dDAVP-responsive miRNAs target rat Calm1 (rno-miR-1, rno-miR-206, and rno-miR-16) and rat Arhgap5 (rno-miR-16) according to the rat miRNA database. In the mouse miRNA database, mouse Avpr2 (mmu-miR-298), mouse Gnas (mmu-miR-678 and mmu-miR-298), mouse Calm1 (mmu-miR-206 and mmu-miR-16), and mouse Arhgap5 (mmu-miR-16) were targeted. Moreover, miRNAs targeting the AQP2 gene were predicted to target other genes simultaneously, including rat Prkar1a (rno-miR-32), rat Pik3ca (rno-miR-32 and rno-miR-137), mouse Prkar1a (mmu-miR-32), mouse Pik3ca (mmu-miR-32 and mmu-miR-137), and mouse Akt1 (mmu-miR-32). mRNAs of other target genes also contained identical core sequences that are targeted by miR-32 (3=-. . . ACGUUA . . . -5=) or miR-137 (3=-. . . CGUUAU . . . -5=); however, the degree of complementarity of these miRNAs for the recognition of mRNAs might be variable. We examined whether these two miRNAs (miR-32 and miR-137) could regulate mRNA levels of several selected target genes (Sgk3, Tgif1, and Traf3 for miR-32; Gpr137b, Mapkapk2, and Myo1c for miR-137). However, none of these genes were significantly regulated at least at mRNA levels. Since the target sequences of miR-32 and miR-137 exist in mRNAs of vasopressinregulated genes, further study on target genes of these miRNAs could provide comprehensive information about miRNA-regulated AQP2 expression in kidney collecting duct cells.
In conclusion, the present study demonstrates dDAVP-responsive miRNAs and specific miRNAs targeting AQP2 and provides novel insights demonstrating that AQP2 expression could be, at least in part, regulated by RNA interference. 
